Join us virtually on February 17th at 3pm PST | 6 PM EST as Dr. Hande Ozdinler describes the groundbreaking work underway that looks at the brain motor neurons as a target for developing ALS therapies.

Moderator

Taner Dagdelen

Taner Dagdelen is the CEO & Co-founder of Unite Genomics.

Speaker

Dr. Hande Ozdinler

Dr. Hande Ozdinler is an Associate Professor of the Department of Neurology at Northwestern University and Faculty at the Chemistry of Life Processes Institute, Les Turner ALS Center, Cognitive Neurology and Alzheimer's Disease Center and the Robert H. Lurie Comprehensive Cancer Research Center.